Aristotle Capital Boston LLC decreased its position in shares of Cross Country Healthcare, Inc. (NASDAQ:CCRN - Free Report) by 10.1% in the 4th quarter, according to its most recent 13F filing with the SEC. The firm owned 860,695 shares of the business services provider's stock after selling 96,730 shares during the quarter. Aristotle Capital Boston LLC owned approximately 2.62% of Cross Country Healthcare worth $15,630,000 at the end of the most recent quarter.
Several other large investors also recently added to or reduced their stakes in CCRN. Magnetar Financial LLC bought a new position in Cross Country Healthcare during the fourth quarter worth about $41,421,000. Alliancebernstein L.P. grew its stake in Cross Country Healthcare by 443.7% in the 4th quarter. Alliancebernstein L.P. now owns 1,284,940 shares of the business services provider's stock valued at $23,335,000 after buying an additional 1,048,605 shares in the last quarter. AQR Arbitrage LLC bought a new stake in Cross Country Healthcare during the 4th quarter valued at $10,851,000. Alpine Associates Management Inc. bought a new position in shares of Cross Country Healthcare in the fourth quarter worth $10,552,000. Finally, Chicago Capital Management LLC purchased a new position in shares of Cross Country Healthcare in the fourth quarter valued at $7,300,000. Hedge funds and other institutional investors own 96.03% of the company's stock.
Cross Country Healthcare Trading Down 0.7 %
Shares of CCRN traded down $0.10 during trading hours on Monday, reaching $13.51. 201,157 shares of the company's stock traded hands, compared to its average volume of 592,691. Cross Country Healthcare, Inc. has a 12 month low of $9.58 and a 12 month high of $18.50. The stock has a market cap of $442.94 million, a PE ratio of -270.15, a price-to-earnings-growth ratio of 3.32 and a beta of 0.25. The firm's 50 day simple moving average is $14.87 and its 200-day simple moving average is $15.39.
Analyst Ratings Changes
CCRN has been the subject of several analyst reports. StockNews.com assumed coverage on Cross Country Healthcare in a research note on Tuesday, April 29th. They issued a "hold" rating for the company. JMP Securities restated a "market perform" rating on shares of Cross Country Healthcare in a research report on Thursday, February 6th. Finally, Barrington Research reaffirmed a "market perform" rating and set a $18.61 target price on shares of Cross Country Healthcare in a report on Friday, March 14th. Six equities research analysts have rated the stock with a hold rating, Based on data from MarketBeat.com, the company currently has a consensus rating of "Hold" and an average price target of $18.41.
Read Our Latest Analysis on CCRN
About Cross Country Healthcare
(
Free Report)
Cross Country Healthcare, Inc provides talent management and other consultative services for healthcare clients in the United States. The company's Nurse and Allied Staffing segment provides traditional staffing, recruiting, and value-added total talent solutions, including temporary and permanent placement of travel and local nurse and, allied professionals; temporary placement of healthcare leaders within nursing, allied, physician, and human resources; vendor neutral and managed services programs; education healthcare services; in-home care services; and outsourcing services.
See Also

Before you consider Cross Country Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cross Country Healthcare wasn't on the list.
While Cross Country Healthcare currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.